Cargando…

Neuroprotective Activities of Curcumin in Parkinson’s Disease: A Review of the Literature

Parkinson’s disease (PD) is a slowly progressive multisystem disorder affecting dopaminergic neurons of the substantia nigra pars compacta (SNpc), which is characterized by a decrease of dopamine (DA) in their striatal terminals. Treatment of PD with levodopa or DA receptor agonists replaces the fun...

Descripción completa

Detalles Bibliográficos
Autor principal:	Nebrisi, Eslam El
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537234/ https://www.ncbi.nlm.nih.gov/pubmed/34681908 http://dx.doi.org/10.3390/ijms222011248

Ejemplares similares

Neuroprotective Effect of Curcumin on the Nigrostriatal Pathway in a 6-Hydroxydopmine-Induced Rat Model of Parkinson’s Disease is Mediated by α7-Nicotinic Receptors
por: El Nebrisi, Eslam, et al.
Publicado: (2020)

Neuroprotective properties of curcumin in toxin-base animal models of Parkinson’s disease: a systematic experiment literatures review
por: Wang, Xin-Shi, et al.
Publicado: (2017)

Curcumin modulation of L-dopa and rasagiline-induced neuroprotection in rotenone model of Parkinson’s disease
por: El-Shamarka, Marwa El-Sayed, et al.
Publicado: (2023)

Neuroprotective effects of curcumin on the cerebellum in a rotenone‐induced Parkinson’s Disease Model
por: Fikry, Heba, et al.
Publicado: (2022)

Curcumin, Gut Microbiota, and Neuroprotection
por: Di Meo, Francesco, et al.
Publicado: (2019)

Curcumin as a Promising Neuroprotective Agent for the Treatment of Spinal Cord Injury: A Review of the Literature
por: Lee, Subum, et al.
Publicado: (2022)

Curcumin and Heme Oxygenase: Neuroprotection and Beyond
por: Mhillaj, Emanuela, et al.
Publicado: (2019)

Curcumin Regulates Gut Microbiota and Exerts a Neuroprotective Effect in the MPTP Model of Parkinson's Disease
por: Zhu, Hong, et al.
Publicado: (2022)

Uncovering the Neuroprotective Mechanisms of Curcumin on Transthyretin Amyloidosis
por: Ferreira, Nelson, et al.
Publicado: (2019)

Topical Curcumin Nanocarriers are Neuroprotective in Eye Disease
por: Davis, Benjamin M., et al.
Publicado: (2018)

Aerobic Exercise and Healthy Nutrition as Neuroprotective Agents for Brain Health in Patients with Parkinson’s Disease: A Critical Review of the Literature
por: Cammisuli, Davide Maria, et al.
Publicado: (2020)

Neuroprotection or Neurotoxicity of Illicit Drugs on Parkinson’s Disease
por: Ferreira, Carla, et al.
Publicado: (2020)

Neuroprotection and Disease Modification by Astrocytes and Microglia in Parkinson Disease
por: Takahashi, Shinichi, et al.
Publicado: (2022)

Multifunctional Metallothioneins as a Target for Neuroprotection in Parkinson’s Disease
por: Miyazaki, Ikuko, et al.
Publicado: (2023)

Neuroprotective Properties of Green Tea (Camellia sinensis) in Parkinson’s Disease: A Review
por: Malar, Dicson Sheeja, et al.
Publicado: (2020)

Exploring the Neuroprotective Mechanism of Curcumin Inhibition of Intestinal Inflammation against Parkinson’s Disease Based on the Gut-Brain Axis
por: Zhong, Lifan, et al.
Publicado: (2022)

The Neuroprotective Effects of Cannabis-Derived Phytocannabinoids and Resveratrol in Parkinson’s Disease: A Systematic Literature Review of Pre-Clinical Studies
por: Prakash, Samay, et al.
Publicado: (2021)

Mitochondrial Dysfunction in Parkinson's Disease: Pathogenesis and Neuroprotection
por: Mounsey, Ross B., et al.
Publicado: (2010)

Neuroprotective Function of DJ-1 in Parkinson's Disease
por: Ariga, Hiroyoshi, et al.
Publicado: (2013)

On the role of endogenous neurotoxins and neuroprotection in Parkinson's disease
por: Segura-Aguilar, Juan
Publicado: (2017)

The Neuroprotective Disease-Modifying Potential of Psychotropics in Parkinson's Disease
por: Lauterbach, Edward C., et al.
Publicado: (2012)

Neuroprotection in Parkinson’s disease: facts and hopes
por: Salamon, András, et al.
Publicado: (2019)

Neuroprotection by immunomodulatory agents in animal models of Parkinson’s disease
por: Martinez, Bridget, et al.
Publicado: (2018)

Targeting AMPK Signaling as a Neuroprotective Strategy in Parkinson’s Disease
por: Curry, Daniel W., et al.
Publicado: (2018)

Neurodegeneration and neuroprotection in Parkinson's disease /
Publicado: (1996)

Cellular and Molecular Targets of Menthol Actions
por: Oz, Murat, et al.
Publicado: (2017)

Neuroprotective Activities of Palmitoylethanolamide in an Animal Model of Parkinson's Disease
por: Esposito, Emanuela, et al.
Publicado: (2012)

Neuroprotective Transcription Factors in Animal Models of Parkinson Disease
por: Blaudin de Thé, François-Xavier, et al.
Publicado: (2016)

Neuroprotective and Therapeutic Strategies against Parkinson’s Disease: Recent Perspectives
por: Sarkar, Sumit, et al.
Publicado: (2016)

Neuroprotective Surgical Strategies in Parkinson’s Disease: Role of Preclinical Data
por: Torres, Napoleon, et al.
Publicado: (2017)

Neuroprotective Effect of Melatonin on Sleep Disorders Associated with Parkinson’s Disease
por: Hu, Xinyu, et al.
Publicado: (2023)

Molecular mechanisms underlying the neuroprotection of environmental enrichment in Parkinson’s disease
por: Alarcón, Tamara Andrea, et al.
Publicado: (2022)

Mitochondrial therapy for Parkinson’s disease: Neuroprotective pharmaconutrition may be disease-modifying
por: Kones, Richard
Publicado: (2010)

Neuroprotective Effects of Curcumin in Methamphetamine-Induced Toxicity
por: Ryskalin, Larisa, et al.
Publicado: (2021)

Neuroprotective and Neurological/Cognitive Enhancement Effects of Curcumin after Brain Ischemia Injury with Alzheimer’s Disease Phenotype
por: Pluta, Ryszard, et al.
Publicado: (2018)

The Promise of Neuroprotective Agents in Parkinson’s Disease
por: Seidl, Stacey E., et al.
Publicado: (2011)

Microglial Ion Channels as Potential Targets for Neuroprotection in Parkinson's Disease
por: Richardson, Jason R., et al.
Publicado: (2013)

Recent Advances on the Neuroprotective Potential of Antioxidants in Experimental Models of Parkinson’s Disease
por: Koppula, Sushruta, et al.
Publicado: (2012)

Promising cannabinoid-based therapies for Parkinson’s disease: motor symptoms to neuroprotection
por: More, Sandeep Vasant, et al.
Publicado: (2015)

Addressing the Neuroprotective Actions of Coffee in Parkinson’s Disease: An Emerging Nutrigenomic Analysis
por: Lee, Lai Kuan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rfckru4l8k0fe3leibn95se95u